Prologis, Inc. (PLD) launches $2.1B stock sale with option for $2.4B
Rhea-AI Filing Summary
Prologis, Inc. entered into an underwriting agreement with J.P. Morgan Securities LLC and BofA Securities, Inc. for an underwritten public offering of 15,000,000 shares of common stock. The transaction is expected to provide net proceeds of approximately $2.1 billion, or approximately $2.4 billion if the underwriters fully exercise a 30‑day option to purchase an additional 2,250,000 shares to cover over‑allotments. The offering is expected to close on August 5, 2026.
The offering is being made under an effective shelf registration statement using a base prospectus and an August 4, 2026 prospectus supplement. Prologis has agreed not to sell additional common stock or related convertible or exercisable securities for 30 days after August 4, 2026 without consent from the underwriters, subject to exceptions. The company intends to contribute the cash proceeds to Prologis, L.P. in exchange for operating partnership units, and the operating partnership intends to use the proceeds for general corporate purposes, including funding potential acquisitions such as SEGRO plc, although there is no assurance that the SEGRO plc combination will be completed.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Shares offered: 15,000,000 shares
Net proceeds (base offering): $2.1 billion
Over-allotment option shares: 2,250,000 shares
+3 more
6 metrics
Shares offered
15,000,000 shares
Underwritten public offering of common stock announced August 4, 2026
Net proceeds (base offering)
$2.1 billion
Expected net proceeds after expenses from 15,000,000-share offering
Over-allotment option shares
2,250,000 shares
Additional common stock available to underwriters to cover over-allotments
Net proceeds with option exercised
$2.4 billion
Expected net proceeds if 2,250,000-share option is exercised in full
Lock-up period
30 days
Restriction on additional stock or related securities sales after August 4, 2026
Shelf registration file number
333-289636
Effective shelf registration statement used for the offering
Key Terms
underwritten public offering, over-allotments, shelf registration statement, prospectus supplement, +1 more
5 terms
underwritten public offering financial
"in connection with an underwritten public offering of 15,000,000 shares of its common stock"
An underwritten public offering is when a company sells new shares of its stock to the public with the help of a financial firm, called an underwriter. The underwriter agrees to buy all the shares upfront, reducing the company's risk, and then sells them to investors. This process helps companies raise money quickly and confidently from a wide range of buyers.
over-allotments financial
"option to purchase an additional 2,250,000 shares of Common Stock solely to cover over-allotments"
An over-allotment is a temporary extra batch of shares that the underwriters of a stock offering are allowed to sell beyond the original amount, with the right to buy those shares back later. Think of it as spare tickets sold to meet demand and then reclaimed if needed to keep the market orderly; it helps stabilize the stock price after an offering and can affect short-term supply and potential dilution, which matters to investors tracking price and ownership stakes.
shelf registration statement regulatory
"The offering is being made pursuant to an effective shelf registration statement (File No. 333-289636)"
A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.
prospectus supplement regulatory
"and a prospectus supplement, dated August 4, 2026, filed with the Securities and Exchange Commission"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
general corporate purposes financial
"The Operating Partnership intends to use such net proceeds for general corporate purposes, including to fund potential acquisitions"
"General corporate purposes" refer to the broad range of activities and expenses a company can use its funds for to support its overall operations and growth. This can include things like paying bills, investing in new projects, or strengthening its financial position. For investors, understanding this term helps clarify how a company plans to use its resources to sustain and expand its business over time.
Offering Details
shelf
Offering
Offering Type
shelf
Use of Proceeds
Contribute proceeds to Prologis, L.P., which will use them for general corporate purposes, including potential acquisitions such as SEGRO plc.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity offering did Prologis (PLD) announce on August 4, 2026?
Prologis announced an underwritten public offering of 15,000,000 shares of its common stock. The deal includes an additional 2,250,000-share option for underwriters to cover over‑allotments, exercisable for 30 days from August 4, 2026.
How much capital will Prologis (PLD) raise from this stock offering?
Prologis expects net proceeds of approximately $2.1 billion from the offering. If underwriters fully exercise their 2,250,000‑share option, net proceeds would increase to approximately $2.4 billion, after deducting estimated expenses payable by the company.
What is the purpose of the new equity proceeds for Prologis (PLD)?
Prologis intends to contribute the cash proceeds to Prologis, L.P. in exchange for operating partnership units. The operating partnership plans to use the net proceeds for general corporate purposes, including funding potential acquisitions such as SEGRO plc.
Is the SEGRO plc transaction by Prologis (PLD) guaranteed to close?
No. Prologis states there can be no assurance it will complete the SEGRO plc combination. The company notes uncertainty regarding completion on the proposed terms, on the anticipated timeline, or at all.
What lock-up restrictions apply to Prologis (PLD) after this offering?
Under the underwriting agreement, Prologis agreed not to sell or transfer common stock or related convertible/exercisable securities for 30 days after August 4, 2026 without prior written consent from J.P. Morgan Securities LLC and BofA Securities, Inc., subject to specified exceptions.
Under what registration does Prologis (PLD) conduct this stock offering?
The common stock offering is being made under an effective shelf registration statement (File No. 333-289636), using a base prospectus dated August 15, 2025 and a prospectus supplement dated August 4, 2026 filed under Rule 424(b).